N
ORC at the University of Chicago, working with a team of investigators, conducted approximately 3,400 in-person interviews for the second wave of the National Social Life, Health, and Aging Project (NSHAP). NSHAP is a longitudinal, population-based study of health and social factors that provides information about the well-being of older, community-dwelling adults by examining the interactions among physical health, illness, medication use, cognitive function, emotional health, sensory function, health behaviors, social connectedness, sexuality, and relationship quality.
In 2005 and 2006, the first wave of NSHAP was conducted from a nationally representative sample of adults in the United States aged 57-85. Wave 1 of NSHAP was designed to: (a) describe the health of older communityresiding Americans; (b) evaluate the relationship between older adults' health and interpersonal connections; (c) examine the importance of gender and socioeconomic context for older adults' health and social connectedness; (d) identify biological pathways through which social connectedness affects aspects of health; and (e) describe health behaviors and health care utilization among older adults and gauge their perceptions about physicianpatient communication and health care services. NSHAP field interviewers completed 3,005 interviews in Wave 1, achieving a weighted response rate of 75.5%. Details of the Wave 1 data collection plan can be found in Smith and colleagues (2009) .
The primary objectives in conducting a second wave of NSHAP were to expand the data available to allow for longitudinal analyses of long-term health trajectories and to better characterize the impact of marital and romantic relationships on health. To accomplish these goals, NSHAP returned to interview respondents from Wave 1 and, for the first time, to interview their cohabiting spouses and romantic partners. In 2010 and 2011, 5 years after Wave 1, NSHAP field interviewers returned to the field to complete Wave 2. This article describes both innovation in the development and implementation of Wave 2 as well fidelity to the Wave 1 study design and data collection procedures.
As in Wave 1, Wave 2 data collection included three main components: a 2-hr face-to-face interview, biomeasure collection, and a self-administered paper-and-pencil questionnaire (PAPI). Data collection for the face-to-face interviews occurred in the respondent's home and was administered via Computer-Assisted Personal Interview (CAPI). The interview elicited information regarding (a) demographic characteristics, (b) social networks, (c) physical health, (d) history of sexual and intimate partnerships, (e) fertility and menopause, (f) children and grandchildren, (g) mental health, (h) employment and finances, and (i) religion. NSHAP also collected important biological measures in the home, prioritizing noninvasive collection techniques and cutting-edge technology that minimizes respondent burden. The NSHAP Wave 2 interview included the collection of up to 15 biological measures and biospecimens: height, weight, hip circumference, waist circumference, blood pressure, heart rate and preventricular contraction, physical performance measures including timed walk and chair stands, smell, saliva collection using a synthetic sponge called a Salivette (cortisol), saliva passive drool in a tube (dehydroepiandrosterone, estradiol, progesterone, testosterone) , dried blood spots (Epstein-Barr virus antibody titers, C-reactive protein, glycosylated hemoglobin, hemoglobin, cholesterol, high-density lipoprotein), whole blood in a microtainer (cytokines), urine (creatinine, vasopressin, oxytocin) , Oragene (genotype), respondent-administered vaginal swabs (bacterial vaginosis, yeast, and vaginal cell cytology), and Actiwatch (sleep patterns and activity). At the end of the in-person interview, respondents were given a supplemental PAPI, also known as the "Leave-Behind Questionnaire" (LBQ). To reduce respondent burden at the time of the interview, measures that could be answered independently of the in-person interview were included in this questionnaire. The LBQ took approximately 30 min for respondents to complete on their own.
In addition to the three main data collection components, a new, short, exit questionnaire was developed for Wave 2 to collect final health data for Wave 1 panel respondents who were deceased or in too poor health to participate in Wave 2. Ideal proxy respondents were identified as a person close to the Wave 1 Respondent (such as a spouse, child, close relative or friend) who would be able to answer questions about the respondent's health prior to his/her death or illness.
Wave 2 Sample
The Wave 2 sample was comprised of three types of respondents. More detail about the sampling process for each type of respondent can be found in the O'Muircheartaigh, English, Pedlow, and Kwok (2014) in this issue.
Wave 1 Respondents
To meet the objective of expanding the dataset for longitudinal data analysis, interviewing respondents from Wave 1 was paramount to data collection efforts. Wave 1 Respondents were those respondents who completed an interview during the first wave of data collection in [2005] [2006] . Respondents who completed the interview in both Waves 1 and 2 constitute the panel component of NSHAP and allow population-based longitudinal analysis of health, sexuality, and social relationships.
New for Wave 2: Partners
Coresidential spouses or romantic partners of Wave 1 Respondents were introduced in Wave 2 to meet the study's objective for allowing a more thorough analysis of the roles that partners and intimate relationships play in both respondents' health and well-being. While the Wave 1 interview collected self-reported data from respondents about their spouses and romantic partnerships, interviewing these Partners directly in Wave 2 facilitates the assessment of the characteristics of the relationship such as support, closeness and mistreatment, and the health of each of the partners. Partners were identified by the Wave 1 Respondent and were defined as a spouse or romantic partner who lived in the same household (at the time of interview) as the Wave 1 Respondent. Partners who were at least 18 years of age at the time of interview were eligible to participate.
New for Wave 2: Wave 1 Non-Interviewed Respondents
A common challenge in longitudinal studies is that the gradual attrition of the panel across waves results in fewer cases for analysis and increases the risk of bias. For this reason, NSHAP also included Wave 1 Non-Interviewed Respondents (referred to as Wave 1 NIRs throughout the paper) in the Wave 2 sample. Wave 1 NIRs were included in the second wave in an effort to increase the Wave 2 response rate, increase the representativeness of the Wave 2 sample, and recover additional demographic data for Wave 1 NIRs. A total of 1,012 cases were coded as NIRs in Wave 1. Those sampled for Wave 1 but who were deemed hostile when contacted were removed from the Wave 2 sample. The remaining 824 non-hostile Wave 1 NIRs were approached for participation in NSHAP in Wave 2.
Wave 2 Methods
Given the longitudinal goals of NSHAP, most of the Wave 2 in-person questionnaire and biomeasure data collection remained unchanged from Wave 1. This stability allowed for measurement of change in the various aspects of respondents' lives. Following extensive review and analysis by the investigator team, some modifications to the questionnaire, biomeasures, and biomeasure protocols were implemented. Investigators also collaborated with the NSHAP Advisory Board between waves of data collection to elicit additional input on data collection and analysis plans for Wave 2.
Biomeasure Development
A fundamental component of both waves of NSHAP is the collection of biomeasures to objectively assess health status and disease. Biomeasures encompass a broad range of biological, anthropometric, functional, and sensory measurements. Building on Wave 1 successes, the Wave 2 biomeasure collection and shipping procedures were collaboratively reviewed, refined, and enhanced by an interdisciplinary NSHAP biomeasure working group.
Innovative biomeasures were also added to Wave 2, such as hip circumference, Actiwatch (sleep patterns and activity), whole blood in a microtainer (cytokines), saliva collection using a synthetic sponge called a Salivette (cortisol), Oragene (genotype), and urine (creatinine, vasopressin, oxytocin) . Weighing the specific aims of the study with the interview length and budget, the NSHAP research team agreed that some biomeasures should be dropped from Wave 2. Table 1 
Biomeasures Substudies and Respondent Groups
Due to constraints on the budget and on the length of the interview, we were not able to collect all biomeasures from every respondent. Instead, we administered a core set to all respondents, while identifying specific biomeasures for which administration to a subset of the sample was adequate to meet our analytic objectives. The core set of biomeasures collected from all participants in the interview included anthropometrics, cardiovascular function, physical performance, and neurocognition. All participants were asked to provide saliva, assayed for reproductive hormones, and blood specimens assayed for biomeasures of cardiovascular, immune and kidney function, glucose and lipid metabolism, and psychosocial behavior (see Table 2 in O' Doherty et al., 2014) .
In a set of five substudies, NSHAP collected additional biospecimens from two-thirds of the sample as well as a test of olfaction (smell): (a) Salivettes for stress hormones, (b) urine for social peptides and kidney function along with vaginal swabs for infection and reproductive hormones, (c) olfactory function, and (d) Oragene for genotyping. At least half of respondents in each substudy overlapped with those in each of the other substudies (e.g., of those assigned to the Salivettes stress hormone study [see rows in Figure 1 ], half were also assigned to the urine, olfaction, and Oragene substudies); and (e) the fifth substudy of sleep and daytime activity using an Actiwatch was administered to one-third of the sample, since these were the most expensive biomeasures to collect and since 850 observations (allowing for projected item-nonresponse) provide approximately 90% power to detect relationships between sleep-activity parameters and health outcomes of the magnitudes that have been reported in the literature. All Actiwatch participants were assigned to the Salivettes and Oragene substudies and half to urine/vaginal swabs and olfaction.
To implement this overlapping substudy strategy in the field, we created six different groups of respondents that would participate in distinct combinations of the five substudies (see columns 1-6 in Figure 1 ). Respondents were randomly assigned with equal probability to one of six respondent groups, with partners being assigned to the same respondent group as the referent respondent. Each respondent group provided a different set of biospecimens and biomeasures administered in the same overall order, and thus each corresponds to a different "path" through the interview. Figure 1 shows these six respondent groups, together with the number of respondents assigned to each. Using group 1 as an example, respondents assigned to this group provided the core biomeasures and participated in three substudies ([b] urine and vaginal swab collection, [c] olfactory function (smell), and [d] Oragene for genotyping), but did not provide (a) Salivettes or (e) Actiwatch data.
The overlapping substudy design provides approximately 90% power (assuming a design effect of 1.5 and two-sided α of .05) to detect correlations of .09 between a biomeasure obtained from a substudy with other variables collected from the whole sample and .13 between any two biomeasures across these substudies. For analyses involving a binary variable, two-thirds of the sample provides Note. (○) = not included in data collection; (•) = included in data collection, (▲) = enhanced, comparable versions included in data collection. BV = bacterial vaginosis; CRP = C-reactive protein; DHEA = dehydroepiandrosterone; EBV = Epstein-Barr virus; HDL = high-density lipoprotein; HPV = human papillomavirus; HR = heart rate; NSHAP = National Social Life, Health, and Aging Project; PVC = preventricular contraction. approximately 90% power to detect odds ratios in the range of 1.2-1.4 (depending on the overall proportion, and assuming a standardized continuous covariate). Such effect sizes are similar (and in some cases smaller) than what we expect for relationships involving these biomeasures, based on our analyses of data from Wave 1 (e.g., odor identification and vaginal estrogenization) and published studies. Finally, although Oragene for genotyping was only collected from two-thirds of the sample, it will be possible to perform targeted genotyping in the other third using the blood samples (we have confirmed this using left-over material from the Wave 1 dried blood spots), yielding data that may either be pooled with the data from the Oragene samples or used for replication.
New for Wave 2: Partner Interviewing
Partner identification.-One of the operational challenges in adding Partners to NSHAP for Wave 2 was creating a uniform method for identifying spouses and romantic partners as respondents. To meet this challenge, the instrument was designed so that Wave 1 Respondents identified Partners through a series of questions administered during the Social Network Roster section of their own interview. These questions elicited information about the Wave 1 Respondent's marital status and/or whether they considered anyone to be a romantic partner. If a romantic partner or spouse was identified, follow-up questions in this section also confirmed the Partner's eligibility to participate by having the Wave 1 Respondent report the spouse or romantic partner's age and the cohabiting status of the spouse or romantic partner. Once an eligible cohabiting spouse or romantic partner was identified, the CAPI instrument was designed to create a new questionnaire in the case management system for later administration to the Partner.
Partner experiment.-Due to the sensitive information collected in NSHAP, an experiment was designed and implemented throughout Wave 2 data collection in order to assess any potential bias subsequently introduced into Wave 1 Respondent data related to the addition of Partner interviews (i.e., would Wave 1 Respondents answer questions differently if they knew their partner would answer the same questions; partners of Wave 1 NIRs were defined as in-scope mid-way through data collection and were not part of the Partner experiment). Using partner status from Wave 1 (i.e., whether or not the Wave 1 Respondent had a cohabiting spouse or romantic partner that would have fit the Wave 2 definition), Wave 1 Respondents were assigned to one of three experimental conditions: "Tell-Before," "Tell-After," and "Do Not Interview Partner." Table 2 outlines the specific logic upon which group assignments were made and executed in the CAPI instrument. Execution of the "TellBefore" and "Tell-After" conditions was predicated on identification of an eligible Partner in the Roster section of the Wave 1 Respondent interview.
Because of the longitudinal nature of NSHAP, collecting data from Wave 1 Respondents was prioritized over collecting data from Partners. To minimize risk of Wave 1 Respondent nonresponse, Wave 1 Respondents were always interviewed before their eligible Partner within the Partner Experiment. In the "Tell-Before" condition (n =1,134), Wave 1 Respondents were told about our intention to interview their partner before (or at the beginning of) their own interview. In the "Tell-After" condition (n = 827), Wave 1 Respondents were told about our intention to interview their partner after they completed their own interview. Lastly, in the "Do Not Interview Partner" experimental condition (n = 300), partners of Wave 1 Respondents were never approached for a Partner interview. For "Tell-Before" and "Tell-After" conditions, a script was developed and integrated into the CAPI instrument (i.e., "Tell-Before" script at the beginning of the Wave 1 Respondent interview and "Tell-After" script at the end of the Wave 1 Respondent interview) as a prompt for interviewers to tell the Wave 1 Respondent that his/her Partner had been selected for an NSHAP interview. When a Wave 1 Respondent was assigned to the "Tell-Before" condition, and as a gaining cooperation strategy (additional information on this strategy provided in the Gaining Cooperation subsection), the interviewer had the option to mention the Partner interview up-front to the Wave 1 Respondent and before prompted by the CAPI instrument. For all Wave 1 Respondent interviews in the "Tell-After" condition, interviewers waited to mention the Partner interview until prompted by CAPI at the end of the interview. Analysis of the results of the Partner Experiment is in progress.
New for Wave 2: Sleep/Activity Measurement -Actigraphy
Actigraphy was introduced as a biomeasure substudy in Wave 2. Actigraphy is a minimally invasive method used to measure sleep and activity cycles. Further technical details on Actigraphy can be found in Lauderdale and colleagues (2014) in this issue. Overall, 73% of eligible respondents participated in the actigraphy substudy (n = 819).
New for Wave 2: Proxy Questionnaire/Exit Interview
Another new Wave 2 addition to the NSHAP dataset was the collection of an exit interview to collect data from proxies of Wave 1 Panel Respondents who were deceased or were too ill to participate at the time of the Wave 2 interview. Throughout the Wave 2 data collection period, it was determined that 432 Wave 1 Respondents were deceased and 134 were in too poor health to participate. Deceased respondents were coded as out of scope; however, Wave 1 Respondents in too poor health were coded as NIRs. Since incapacitation and mortality are important health outcomes, a short Exit Interview was developed to collect health data about these Wave 1 Respondents from a proxy respondent.
Questionnaire Development
As in Wave 1, the main questionnaire for Wave 2 collected information from a number of domains, including (a) social context, (b) sex and partnership, (c) environmental context, (d) physical health, (e) mental health and personality, and (f) cognitive function. Within each of these domains, some sections remained identical to Wave 1, whereas others were enhanced slightly for Wave 2. Additionally, two new sections were added to the Wave 2 questionnaire, the Social Network Change subsection (see Cornwell, Schumm, Laumann, & Kim, 2014) and measures of cognitive function (see Shega et al., 2014) . Table 3 provides a summary of the domains across both waves.
Questionnaire Administration and Management
The in-person NSHAP Wave 2 interview was conducted in English or Spanish using a CAPI questionnaire. The CAPI program controlled which biomeasure substudy groups were to be administered and which version of the post-interview questionnaire (LBQ) was to be given to the respondent. Respondents were offered the choice of answering a series of questions that some respondents might find to be particularly sensitive in nature in one of two ways: reading the question text on the laptop computer and entering responses directly into the CAPI program or reading and answering the sensitive questions on a separate PAPI that would be given in a sealed envelope to the interviewer.
To minimize interviewer data entry errors, both soft and hard range checks were programmed into the CAPI instrument. The interviewer instructions and the data fields for collecting the in-home biomeasure responses were also incorporated into the CAPI interview. Hardcopy respondent materials (e.g., a spiral bound book with selected question text and response options, life history calendar) were also used to facilitate questionnaire administration.
Data Collection
Like questionnaire modifications, Wave 2 data collection protocols were largely adapted from those successfully employed in the first wave of NSHAP. Building on Wave 1 protocols, procedures were carefully designed for all aspects of Wave 2 data collection, including: field staff preparations, informed consent, processes to conduct the in-home interviews including the collection of biomeasures, and the post-interview questionnaire. The complexity of the interview required comprehensive and efficient protocols for all data collection tasks.
Field Interviewer Recruitment
As is the case in most surveys, interviewers are often the "face" of the project to respondents and are therefore critical to its ultimate success. NORC experienced interviewers were staffed wherever possible. In addition, an effort was made to staff Wave 2 with as many interviewers as possible that also worked on Wave 1 five years prior. It was, however, necessary to hire a small number of new-to-NORC interviewers in areas where the sample did not overlap with geographic regions in which NORC had existing field staff. Because of the biomeasures included in NSHAP, the recruitment process also focused on the ability and willingness of interviewers to learn new skills. Potential interviewers were given fact sheets about the biomeasures that they would be collecting as well as information about storing and shipping biological samples. In addition, they were also shown pictures of the biomeasure collection techniques and when possible shown the actual equipment used to collect the biomeasures. In order to reduce potential early interviewer attrition due to the challenging nature of some of the tasks interviewers were asked to complete, the NSHAP project team wanted to make sure interviewers were comfortable with all elements of the interviewing role prior to being staffed on the project.
Field Interviewer Training
Interviewer training followed many of the successful strategies developed in Wave 1 and included the completion of a home study packet, attendance at a 5-day in-person training in Chicago, and participation in "refresher" trainings throughout data collection. In total, 122 field interviewers and 12 field managers completed the NSHAP training in August and September of 2010. Prior to the in-person training, interviewers were required to complete a home study packet that included reviewing the training manual, watching a DVD demonstrating biomeasure collection and shipping procedures, and answering questions about the project. Interviewers then attended an in-person training that consisted of three project training days, a self-study day, and a certification day. The three project trainings days were taught through a series of brief lectures, hands-on practice drills and mocks, and individual instruction. For biomeasure training, a standardized technique was used for each of the 15 measures: the trainer first would explain the collection procedure; the trainer would then demonstrate the collection procedure with a "respondent"; and finally, the interviewer would practice the collection procedure. The final day of training required interviewers to pass a certification interview. NSHAP interviewers also had to complete at least one practice interview after returning home before entering the field.
Gaining Cooperation
Gaining the cooperation of respondents is essential to the success of any project and especially important in longitudinal studies. In 2009, a year before NSHAP's second wave entered the field, a letter and postcard addressed to NORC were sent to Wave 1 Respondents informing them of our intent to return for a follow-up interview in 2010 and requesting they confirm or update their contact information for the study. Postcards were returned by 928 Wave 1 Respondents (31% of the Wave 1 completed cases). Two weeks before data collection began, advance letters were sent to Wave 1 Respondents and Wave 1 NIRs to notify them that they would soon be visited by a NSHAP interviewer and to request their participation in Wave 2.
Data collection began on August 24, 2010 and lasted 39 weeks. In the field, interviewers had access to a wide assortment of gaining cooperation resources to best customize contact strategies. The case management system provided interviewers not only with a respondent's sample type (Wave 1 Respondent, Partner, or Wave 1 NIR), but also a detailed contact history from both waves of the study. To gain a respondent's cooperation to participate, the interviewer could provide any of the following materials: an NSHAP brochure, examples of questions asked in NSHAP, a letter to community authorities, a handout with information supporting the study's legitimacy, or the health information booklet that showed the results they would receive from the biomeasures. Highlighting research findings from Wave 1 data also substantially helped motivate respondents to participate. To emphasize the importance and legitimacy of NSHAP data, interviewers were provided with a project "dossier" that they could show to the respondent, which contained investigators' biographies, copies of journal articles written using NSHAP Wave 1 data, letters of support from leading research organizations, and press reports on NSHAP. They could also provide respondents with a copy of an article on NSHAP that appeared in the New York Times (Schott, 2009) . In addition to the gaining cooperation materials, NSHAP also offered an initial monetary incentive of $100.
If respondents initially refused to participate, NSHAP mailed customized letters addressing the respondents' specific reasons for refusing. As the field period progressed, NSHAP also sent reluctant respondents a refusal conversion packet in December 2010 containing a small in-kind gift (notepad with project logo) and offered nominal grocery gift cards that could be used locally.
The final refusal conversion effort employed during Wave 2 was an increase of the monetary incentive offered to respondents, from $100 up to a potential total of $400. All incentive amounts (both initial and increases) were reviewed and approved by the Institutional Review Boards (IRBs) of both NORC and the University of Chicago Social and Behavioral Sciences Division. Full details of the Wave 1 and Wave 2 incentive efforts can be found in Colicchia, Czaplewski, and Jaszczak (2012) . A summary of incentives received appears in Table 4 . 
Results Notification for the Biomeasures
In addition to the monetary incentive, providing respondents with their results from the biomeasure collection was an added benefit to participating in the study. At the end of the interview, interviewers provided each respondent with a booklet that contained the respondent's height, weight, waist circumference, hip circumference, blood pressure, pulse, and ratings for smell and physical performance measures. The booklet also provided guidelines for several measures, such as whether respondent weight (according to their body mass index) was below, within, or above a healthy weight, and whether blood pressure was normal, prehypertension, or high according to the American Heart Association. Results from the biological samples collected (e.g., saliva, blood spots, urine, and vaginal swabs) were either experimental or not clinically validated and, therefore, were not reported to respondents.
Shipping of the Biospecimens
Interviewers were responsible for collecting, storing, packing, shipping, and tracking the biospecimens to several external laboratories. Each interviewer was provided with detailed instructions on storage and shipping requirements, which existed both for the interviewers' safety and to maintain the integrity of the sample. In particular, many biospecimens had specific temperature requirements that had to be followed at each stage of processing to ensure sample quality. All shipping protocols adhered to government FedEx and International Air Transport Association (IATA) shipping guidelines. In some instances, biospecimens were shipped directly to the laboratory performing the assays. Based on these guidelines and requirements for maintaining the integrity of the biospecimens, shipments were made on either a daily, weekly, or monthly basis. For additional information on tracking, shipping and cataloguing of the biospecimens, see O'Doherty and colleagues (2014) in this issue.
Quality Control of the Biospecimens
NORC implements rigorous quality control standards crucial to conducting superior survey research. Continuous monitoring of the biospecimens was performed during data collection to ensure the quality of the data obtained. In particular, the quality control process included:
Reconciliation.-Throughout the data collection period, NORC performed weekly reconciliation tasks to compare the laboratory data with the questionnaire data indicating whether or not a biospecimen was collected and arrived at the appropriate destination. Tracking was performed with an electronic, interactive reconciliation system that allowed for the remote tracking of specimens from the point of inhome collection through the delivery in the final data set. Anomalies were investigated on a flow basis and resolved with the assistance of the field and laboratory staff, field notes, laboratory sample requisition forms, and FedEx tracking numbers.
Laboratory sample quality.-The quality of the samples collected and delivered to outside laboratories for analysis was monitored throughout the data collection period. NSHAP's laboratory partners provided ongoing feedback on the quality of the biospecimens received, including how they were collected, stored, shipped, and received, as well as if the results of the analyses fell within expected ranges.
Postinterview Questionnaire
At the end of the in-person interview, respondents were given a paper-and-pencil self-administered questionnaire to complete at home and return via USPS in a provided postage-paid envelope. For Wave 2, there were two versions of the self-administered questionnaire: one version for respondents who identified a current romantic partner during the interview and a second version for respondents who did not have a current romantic partner. The two questionnaires were identical except for seven additional questions that asked respondents with romantic partners about their current relationship. Both self-administered questionnaires took approximately 30 minutes or less to complete. Eightyseven percent of respondents completed the post-interview questionnaire. Unique human subjects considerations.-As in Wave 1, the in-home interview included the collection of biomeasures. Wave 2 added collection of respondent DNA and the storage of biological specimens for future analysis, presenting the researchers with unique human subjects considerations. The consent documentation process was divided into three main steps described below:
IRB Approval and Informed Consent
Verification to read consent.-At the beginning of the interview, all respondents were asked whether they would like to read the Questionnaire and Physical Measures Consent Form or have the interviewer read the form to them. The respondent was asked to sign the consent form (a copy of the form was given to respondents for their records). The process of verbal consent continued throughout the interview, and the interviewer always confirmed willingness to participate in biomeasure collection prior to each assessment. At any time, the respondent was able to seek and obtain additional information regarding the questions or measures, or withdraw their consent.
DNA analysis consent.-Respondents who were selected for Oragene DNA collection were asked to consent to the analysis of their DNA from their Oragene saliva sample. The form also informed the respondent that if their saliva sample was not usable, the study researchers could conduct DNA analysis using the respondent's blood spots collected during the interview. The respondent was asked to initial and sign the form (a copy of the form was given to respondents for their records). The weighted DNA analysis consent cooperation rate was 83.0%.
Future analysis consent.-Respondents who provided at least one biological sample during the interview were asked to consent to the storage of their remaining samples (saliva, blood and/or urine) for future scientific analyses. Since the expected storage time is an indefinite number of years, respondents were informed should they subsequently change their minds and want their samples removed from storage they could contact the study's principal investigator and their samples would be destroyed. Respondents were asked to initial and sign the form (a copy of the form was given to respondents for their records). The weighted future analysis consent cooperation rate was 94.4%.
Results
Wave 2 data collection began on August 24, 2010 and was completed on May 21, 2011. Table 5 shows a total of 3,005 returning Wave 1 cases and 824 Wave 1 NIR cases that were fielded for Wave 2 of the study (188 hostile Wave 1 NIR cases were excluded from Wave 2; see O'Muircheartaigh et al. in this issue for a complete description of the sample and the response rates). In addition, 1,140 Partners of Wave 1 Respondents and Wave 1 NIR respondents were identified during the field period. Of these 4,969 fielded cases, 658 (13.2%) were identified as out of scope (i.e., they did not meet the eligibility requirements for the study). The majority of these respondents were deceased (586 cases). Other respondents identified as out of scope included those that Table 5 provides an overview of response for all fielded cases as well as for each respondent group. Biomeasure cooperation rates were monitored continuously during the field period. As shown in Table 6 , the cooperation rates (using COOP3; The American Association for Public Opinion Research, 2011) were generally quite high, with 13 of the 15 measures achieving cooperation rates in excess of 90%.
The other component of the data collection was the postinterview questionnaire that was left with the respondent to complete after the interviewer had completed the inhome interview. Respondents who had not returned their questionnaires within 3 weeks of completing the in-person interview were prompted by telephone. The final return rate for the LBQ was 87%.
Discussion
The main objectives for conducting the second wave of NSHAP were to expand the Wave 1 data to allow for longitudinal analyses of long-term health trajectories and to better characterize the impact of marital and romantic health relationships through the introduction of Partners to the sample. A critical methodological and operational challenge in simultaneously meeting both goals was to strike a balance between continuity with the data collected in the first wave and developing innovative measures for Wave 2. To build on the many successes of the first wave, the goal of the Wave 2 instrument and biomeasure development and implementation was to maintain comparability to Wave 1.
While most of the questionnaire and biomeasure collection remained unchanged, some modifications were implemented. These carefully designed modifications ensured both stability with, and improvement upon, the data collected in Wave 1. Maintaining similar data collection protocols across both waves (in-person interview, biomeasure collection, and the LBQ) provided continuity and familiarity for returning respondents.
At the same time, analytical objectives also necessitated innovative additions to the study. While adding Partners and the Partner Experiment to the study presented methodical opportunities to directly examine respondents' social lives, it also provided operational challenges. The potential for missing Wave 2 data due to the death and poor health of the aging sample necessitated the development of an entirely new instrument, the exit interview for collecting proxy data. The need to balance continuity and innovation will be just as, if not more, critical in future waves of the study. As the sample continues to age, careful consideration will be given to the possible need to further supplement the sample with new respondents, while remaining dedicated to the study's goal of providing high quality longitudinal data. Additionally, advancements in the understanding and measurement of biological processes and theoretical and conceptual developments in measures will continue to provide opportunities for innovations that need to be incorporated into NSHAP in a manner that maintains consistency across multiple waves.
NSHAP is a longitudinal survey that has successfully integrated a face-to-face interview in the respondent's home with extensive biomeasure collection across multiple waves. While studies like the Health and Retirement Study (HRS) and the National Longitudinal Study of Adolescent Health (AddHealth) also collect biological measures, other researchers may look to NSHAP as an example of the breadth of minimally invasive biomeasures that are possible to collect in a home-setting with nonmedically trained interviewers. NSHAP demonstrates that returning to NIRs from a prior wave can increase the panel response rate and representativeness of the sample. The project's experience converting NIRs from Wave 1 into participants in Wave 2 may extend to other longitudinal studies.
NSHAP data and documentation are available to registered users through the National Archive of Computerized Data on Aging, within the Interuniversity Consortium for Political and Social Research. More details on how to gain access to the NSHAP data can be found at http://www. Note. HR = heart rate; NSHAP = National Social Life, Health, and Aging Project; PVC = preventricular contraction. a Person-level weights are adjusted for nonresponse by age and urbanicity.
